COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

10.1016/j.phrs.2022.106201

Saved in:

Bibliographic Details
Main Authors:	Ho, Wei Shen, Zhang, Ruirui, Tan, Yeong Lan, Chai, Christina Li Lin
Other Authors:	PHARMACY
Format:	Review
Language:	English
Published:	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Antivirals COVID-19 Small molecule therapeutics Drug discovery Chloroquine (PubChem CID 2719) Ivermectin (PubChem CID 6321424) Lopinavir (PubChem CID 92727) Ritonavir (PubChem CID 392622) Remdesivir (PubChem CID 121304016) Dexamethasone (PubChem CID 5743) Baricitinib (PubChem CID 44205240) Molnupiravir (Pubchem CID 145996610) Nirmatrelvir (PubChem CID 155903259) Chemical compounds studied in this article Hydroxychloroquine (PubChem CID 3652) ACUTE RESPIRATORY SYNDROME IN-VITRO LOPINAVIR-RITONAVIR EBOLA-VIRUS IVERMECTIN INHIBITORS CHLOROQUINE EFFICACY REMDESIVIR DRUG
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/226977
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1016/j.phrs.2022.106201